CA2646194A1 - Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses - Google Patents

Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses Download PDF

Info

Publication number
CA2646194A1
CA2646194A1 CA002646194A CA2646194A CA2646194A1 CA 2646194 A1 CA2646194 A1 CA 2646194A1 CA 002646194 A CA002646194 A CA 002646194A CA 2646194 A CA2646194 A CA 2646194A CA 2646194 A1 CA2646194 A1 CA 2646194A1
Authority
CA
Canada
Prior art keywords
unknown
nih
mgc
lung
lymph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002646194A
Other languages
English (en)
Inventor
Don Adams North
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sky Genetics Inc
Original Assignee
Sky Genetics, Inc.
Don Adams North
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sky Genetics, Inc., Don Adams North filed Critical Sky Genetics, Inc.
Publication of CA2646194A1 publication Critical patent/CA2646194A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
CA002646194A 2006-03-23 2007-03-23 Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses Abandoned CA2646194A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74369906P 2006-03-23 2006-03-23
US60/743,699 2006-03-23
US74726006P 2006-05-15 2006-05-15
US60/747,260 2006-05-15
PCT/US2007/064822 WO2007109797A2 (fr) 2006-03-23 2007-03-23 Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses

Publications (1)

Publication Number Publication Date
CA2646194A1 true CA2646194A1 (fr) 2007-09-27

Family

ID=38523333

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002646194A Abandoned CA2646194A1 (fr) 2006-03-23 2007-03-23 Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses

Country Status (3)

Country Link
EP (1) EP2004862A2 (fr)
CA (1) CA2646194A1 (fr)
WO (1) WO2007109797A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3330278A1 (fr) 2012-02-08 2018-06-06 Ionis Pharmaceuticals, Inc. Modulation de l'arn par ciblage de repetitions
JP7288854B2 (ja) 2016-10-07 2023-06-08 セカルナ・ファーマシューティカルズ・ゲーエムベーハー・ウント・コ・カーゲー がんを治療するための新規アプローチ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183893A1 (en) * 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells

Also Published As

Publication number Publication date
WO2007109797A3 (fr) 2008-10-02
EP2004862A2 (fr) 2008-12-24
WO2007109797A2 (fr) 2007-09-27

Similar Documents

Publication Publication Date Title
CN111961725B (zh) 胰腺癌的检测试剂盒或装置以及检测方法
KR100966271B1 (ko) Ｅｒｃｃ1 발현에 기초한 화학요법을 결정하는 방법
US20060194229A1 (en) Cancer markers and detection methods
CN108138209B (zh) 通过原位扩增制备细胞游离核酸分子的方法
BRPI0712497A2 (pt) perfil de gene, uso de um perfil, método para identificar um perfil, usos de uma sonda e de um kit de microarranjo para a identificação da expressão diferencial de pelo menos um produto de gene de ativação imune, microarranjo, kit de diagnóstico, e, método para tratar um paciente, e para induzir um perfil de gene respondedor em paciente distinguido como um não respondedor.
US20230366034A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
CA2592740A1 (fr) Marqueurs du cancer et procedes de detection
JP2014506459A (ja) 薬理ゲノミクスバイオマーカーを発見するための方法
US11045489B2 (en) Prognostic methods and systems of treatment for acute lymphoblastic leukemia
CN101107367A (zh) 癌症标记物和检测方法
CA2646194A1 (fr) Reactifs de detection du cancer et utilisations de ces reactifs dans le diagnostic et le traitement du cancer par destruction des cellules cancereuses
CA2393864A1 (fr) Appareil et methodes de criblage de medicaments
CN101448959A (zh) 癌症检测试剂以及在病理学和诊断学及癌细胞死亡中的用途
US11542559B2 (en) Methylation-based biomarkers in breast cancer screening, diagnosis, or prognosis
EP2436763B1 (fr) Procédé pour évaluer la métastase dans des ganglions lymphatiques de cancer ou le risque de celle-ci, et kit d'évaluation rapide pour ledit procédé
EP3775212A1 (fr) Procédé et système d'identification de miarn musculaires en tant que biomarqueurs moléculaires et co-adjuvant pour le traitement de l'amyotrophie spinale
KR102158726B1 (ko) Itpr3 유전자 업스트림의 유전자간 영역을 포함하는 지연성 허혈 진단용 dna 메틸화 마커 조성물
KR102646011B1 (ko) Brd3의 단일염기다형성을 이용한 비소세포폐암의 예후 진단방법
KR102152893B1 (ko) 간세포암종 특이 mlh1 유전자에 대한 순환 종양 dna 변이 검출 용도
KR102134176B1 (ko) Arid3a의 다형성을 이용한 비소세포폐암의 예후 진단 방법
EP2723896B1 (fr) Mutations observées en cas de tumeurs pancréatiques
KR101977351B1 (ko) 항암제 저항성 또는 민감성 예측용 조성물
WO2023097197A2 (fr) Compositions et méthodes pour évaluer l'efficacité d'une administration de polynucléotides et d'une thérapie anticancéreuse
EP2258864A1 (fr) Marqueur génétique pour une utilisation dans le traitement de la leucémie
JP2005245362A (ja) 肺癌および頭頸部癌の発症危険率を予測する方法

Legal Events

Date Code Title Description
FZDE Discontinued